Loading...
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
Stock
ALMS
ALMS News & Events
-
Add to Watchlist
Trade ALMS
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Forecast
Technical
Valuation
Financials
Earnings
Should I Buy
News
ALMS News
Analysts Bullish on Century Communities, Target Price Set at $92
Jan 21 2026
Benzinga
Alumis Director Srinivas Akkaraju Purchases 588,235 Shares for ~$10 Million
Jan 17 2026
Fool
Alumis (NASDAQ:ALMS) Acquires 588,235 Shares for $10 Million
Jan 17 2026
NASDAQ.COM
Activist Investors Target Staar Surgical, Alumis, and Other Stocks
Jan 17 2026
Barron's
Russell 2000 Kicks Off 2026 Strong, Surging Over 7% Year-to-Date
Jan 15 2026
Benzinga
Alumis Inc. (ALMS) Reports 65% PASI 90 Achievement for Envudeucitinib in Psoriasis Trials
Jan 14 2026
NASDAQ.COM
Alumis Inc. Closes $345.1 Million Upsized Public Offering
Jan 09 2026
Globenewswire
Alumis Inc. Prices 17.65M Shares at $17 Each, Raising Approximately $300M
Jan 08 2026
Benzinga
Show More News
ALMS Events
01/14 12:10
Alumis Stock Rises 10.2% to $24.37
Alumis is up 10.2%, or $2.26 to $24.37.
01/08 06:30
Morgan Stanley Increases Deal Size to $300M
The deal size was increased to $300M in common stock from $175M in common stock. Morgan Stanley, Leerink, Cantor Fitzgerald and Wells Fargo acted as joint book running managers for the offering.
Show More Events
ALMS Monitor News
Alumis Inc. reaches 52-week high amid market gains
Jan 28 2026
Alumis Inc. shares surge after positive trial results for Envudeucitinib
Jan 06 2026
ALMS Earnings Analysis
No Data
People Also Watch
